S. Louise Phanstiel - 02 Jun 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: S. Louise Phanstiel
Issuer symbol
MYGN
Transactions as of
02 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 17:27:17 UTC
Previous filing
26 Jan 2022
Next filing
22 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +17,275 +22% $0.000000 96,802 02 Jun 2022 Direct F1
holding MYGN Common Stock 33,119 02 Jun 2022 The Phanstiel Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant.